Found: 24
Select item for more details and to access through your institution.
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 199, doi. 10.1007/s10549-020-05617-2
- By:
- Publication type:
- Article
Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 155, doi. 10.1007/s10549-020-05614-5
- By:
- Publication type:
- Article
Metformin is distributed to tumor tissue in breast cancer patients in vivo: A 11C-metformin PET/CT study.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 107, doi. 10.1007/s10549-020-05621-6
- By:
- Publication type:
- Article
The association between soy isoflavone intake and menopausal symptoms after breast cancer diagnosis: a prospective longitudinal cohort study on Chinese breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 167, doi. 10.1007/s10549-020-05616-3
- By:
- Publication type:
- Article
Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 189, doi. 10.1007/s10549-020-05615-4
- By:
- Publication type:
- Article
A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 211, doi. 10.1007/s10549-020-05626-1
- By:
- Publication type:
- Article
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 97, doi. 10.1007/s10549-020-05604-7
- By:
- Publication type:
- Article
Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 145, doi. 10.1007/s10549-020-05607-4
- By:
- Publication type:
- Article
The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 13, doi. 10.1007/s10549-020-05610-9
- By:
- Publication type:
- Article
Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 127, doi. 10.1007/s10549-020-05609-2
- By:
- Publication type:
- Article
LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 31, doi. 10.1007/s10549-020-05613-6
- By:
- Publication type:
- Article
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 181, doi. 10.1007/s10549-020-05612-7
- By:
- Publication type:
- Article
Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 23, doi. 10.1007/s10549-020-05606-5
- By:
- Publication type:
- Article
Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 135, doi. 10.1007/s10549-020-05605-6
- By:
- Publication type:
- Article
HER2 borderline is a negative prognostic factor for primary malignant breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 225, doi. 10.1007/s10549-020-05608-3
- By:
- Publication type:
- Article
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 87, doi. 10.1007/s10549-020-05602-9
- By:
- Publication type:
- Article
Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 53, doi. 10.1007/s10549-020-05592-8
- By:
- Publication type:
- Article
Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 221, doi. 10.1007/s10549-020-05601-w
- By:
- Publication type:
- Article
Behavior of metastatic breast cancer according to subtype.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 115, doi. 10.1007/s10549-020-05597-3
- By:
- Publication type:
- Article
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 61, doi. 10.1007/s10549-020-05596-4
- By:
- Publication type:
- Article
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 77, doi. 10.1007/s10549-020-05598-2
- By:
- Publication type:
- Article
Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 43, doi. 10.1007/s10549-020-05587-5
- By:
- Publication type:
- Article
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 1, doi. 10.1007/s10549-020-05586-6
- By:
- Publication type:
- Article
Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 1, p. 69, doi. 10.1007/s10549-020-05582-w
- By:
- Publication type:
- Article